Searched for
BOTTOMLINE PERFORMANCE
Largecaps lead profit growth, mid & smallcaps outshine in revenue momentum in Q4Large companies saw stronger net profit growth for the March 2026 quarter, driven by one-off gains, despite slower revenue expansion and wi...- Q4 earnings roundup: Raymond Realty, MCX among 19 companies that delivered 100%+ growth in sales and PATA select group of 19 large-cap BSE-listed companies achieved triple-digit growth in both profit and revenue during Q4FY26, indicating stron...
- Hindalco shares decline 2% as Q4 profit falls 51%. Here’s what Nuvama and other brokerages saidHindalco Industries' shares dipped after reporting a 51% YoY decline in net profit to Rs 2,597 crore for the March quarter, despite a 20% r...
- LIC emerges as highest profit-making financial company in Jan-Mar quarterLast week, LIC reported a 23 per cent jump in net profit to record Rs 23,420 crore in the just concluded March quarter as compared to Rs 19...
- LIC emerges as highest profit-making financial company in March quarterLife Insurance Corporation of India has achieved the highest profit in the Indian financial sector for the March quarter. The company repor...
- Aadhar Housing Finance Q4 profit surges 27% to Rs 311 crore on strong growth and expansionAadhar Housing Finance reported 27% Q4 profit growth to Rs 311 crore, driven by strong loan disbursements and business expansion. Assets un...
- Bandhan Bank Q4 results: Profit jumps 68% YoY to Rs 530 crore; NII up marginallyBandhan Bank reported a 68% YoY jump in Q4 profit to ₹530 crore, driven by sharply lower provisions and improved asset quality. NII growth ...
- M&M Financial shares jumps 10% after Q4 profit surges 55% YoY to Rs 873 croreMahindra & Mahindra Financial Services shares jumped 10% after a strong Q4 performance, with net profit rising 55% YoY to Rs 873 crore. Gro...
- IEX Q4 results: Cons PAT rises 11% to Rs 130 crore, revenue up 13% on record electricity volumesIndian Energy Exchange delivered steady quarterly growth driven by record electricity trading volumes, improving revenue and profit, alongs...
- HDB Financial Q4 Results: Profit jumps 41% YoY to Rs 751 crore; co declares Rs 2 per share dividendHDB Financial Q4 Results: HDB Financial on Wednesday reported a 41% year-on-year spike in its Q4 profit at Rs 751 crore from Rs 531 crore a...
- Asian Paints Q2 Results: PAT slumps 28% YoY, misses estimate; co to pay Rs 3.65 dividendThe decline in bottomline came despite a 25 per cent on-year fall in tax expenses and 67 per cent jump in other income during the reported ...
- ICICI Bank Q1 preview: Lender may report strong net profit growth, stable asset qualityThe lender is likely to report 77 per cent year-on-year growth in net profit to Rs 4,596 crore for the quarter ended June, according to a p...
- YES Bank Q1 results: PAT surges 355% YoY to Rs 207 cr, highest in 10 quartersThe strong bottomline performance of the lender was aided by a 41 per cent on-year fall in provisions during the reported quarter.
- ITC’s cigarette volumes may not sustain, Street has worriesITC posted a 4 per cent increase in net profit – the slowest growth in the past 11 quarters.
- Manufacturing contracts in April; Q4 earnings to improve: SBIWe expect corporates to report a topline growth ranging from 10 to 12 per cent in the March quarter, while the bottomline may surpass topli...
- Tata Global Beverages smells good, but can't filter all risksAn improving operating margin profile since the past couple of quarters has been fuelling expectations of a smart recovery in TGB's perform...
- But for cigarettes, ITC’s June quarter show would have been lacklustreWhile ITC’s revenues grew 25% - the highest quarterly growth in the last four years, its net profit grew 15.6% - the lowest in the last fiv...
- Sintex Industries: Results good but investors are nonplussedSintex Industries reported a strong operational performance for the December '12 quarter with improving sales as well as margins.
- Launch of anti-HIV drug Combivir generic a positive development for LupinThe launch of Combivir generic is a positive development for Lupin. However, it will have to share the mkt with competitors viz. Teva & Aur...
- Angel maintains 'Buy' on ZensarAngel Broking has maintain a ‘Buy’ on Zensar Technologies, with a 12-month target price of Rs 280, which has been downgraded by 7 per cent ...
Load More
